Home  >  Products  >  TRIP13 (thyroid hormone receptor interactor 13) Blocking Peptide (the N terminal of TRIP13)(100ug)
TRIP13 (thyroid hormone receptor interactor 13) Blocking Peptide (the N terminal of TRIP13)(100ug)

TRIP13 (thyroid hormone receptor interactor 13) Blocking Peptide (the N terminal of TRIP13)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TRIP13 Antibody(ARP38433_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP38433
Size: 100ug
Weight: 48kDa
Gene: 9319
Format: Lyophilized powder
Target: The thyroid hormone (T3) receptors (TRs) are hormone-dependent transcription factors that regulate expression of a variety of specific target genes. TRIP13 specifically interacts with the ligand binding domain of the TRs. It is a member of Trips (TR-interacting proteins) family. Nearly all of the Trips also show similar ligand-dependent interaction with the retinoid X receptor (RXR), but none interact with the glucocorticoid receptor under any conditions. Trips predict specific functional roles: one is an apparent human homolog of a yeast transcriptional coactivator, one is a new member of a class of nonhistone chromosomal proteins, and one contains a conserved domain associated with ubiquitination of specific target proteins.
Alternative names: 16E1BP
See Full Product Listings >